Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 7/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CASR | P41180 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23329328 | 0.86 | GRIN1 (0.36) | OPRM1OPRK1OPRD1MEN1LMNA | |
| SCHEMBL23329769 | 0.82 | OPRM1 (0.45) | OPRM1OPRK1OPRD1MEN1LMNA | |
| SCHEMBL23836805 | 0.81 | GRIN1 (0.47) | OPRM1OPRK1MEN1LMNAKMT2A | |
| SCHEMBL23330088 | 0.81 | CYP2D6 (0.41) | OPRM1OPRK1LMNAKDM4ESLC22A1 | |
| SCHEMBL23329587 | 0.71 | OPRM1 (0.73) | OPRM1OPRK1OPRD1SLC22A1CYP2D6 | |
| SCHEMBL23329597 | 0.71 | GRIN1 (0.36) | OPRM1OPRK1MEN1LMNAKMT2A | |
| Hydrochloric Acid SCHEMBL5142072 | 0.71 | KMT2A (0.57) | MEN1LMNAKMT2AKDM4ECASR | |
| Hydrochloric Acid SCHEMBL5143647 | 0.71 | MEN1 (0.57) | MEN1LMNAKMT2AKDM4ECYP2D6 | |
| SCHEMBL18174911 | 0.70 | GRIN1 (0.47) | OPRM1OPRK1MEN1LMNAKMT2A | |
| SCHEMBL7003941 | 0.69 | OPRM1 (0.44) | OPRM1OPRK1OPRD1LMNASLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210130316-A1 | MORPHINAN DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS | TAIWANJ PHARMACEUTICALS CO., LTD (TW) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130316-A1 | MORPHINAN DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS | TLR4, TLR1, TLR3 | OPRM1 361/4885OPRK1 945/4885OPRD1 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.